ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RGNX REGENXBIO Inc

15.35
-0.70 (-4.36%)
After Hours
Last Updated: 07:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
REGENXBIO Inc RGNX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.70 -4.36% 15.35 07:30:00
Open Price Low Price High Price Close Price Previous Close
15.79 15.33 16.01 15.35 16.05
more quote information »

Recent News

Date Time Source Heading
24/4/202421:05PRNUSREGENXBIO to Participate in Chardan's 8th Annual Genetic..
28/3/202422:05PRNUSREGENXBIO Announces Lancet Publication of Phase I/IIa Study..
28/3/202407:05PRNUSREGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD..
11/3/202423:00EDGAR2Form 8-K - Current report
11/3/202422:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
08/3/202422:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/3/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:03EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
07/3/202415:20PRNUSREGENXBIO Announces Pricing of Upsized Public Offering of..
07/3/202408:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/3/202408:10PRNUSREGENXBIO Announces Proposed Public Offering of Common Stock
06/3/202408:26EDGAR2Form 144 - Report of proposed sale of securities
05/3/202423:05PRNUSREGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM..
01/3/202408:57PRNUSREGENXBIO to Host Webcast Event to Discuss New Interim..
28/2/202408:54EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202408:10EDGAR2Form 8-K - Current report
28/2/202408:05PRNUSREGENXBIO Reports Fourth Quarter and Full Year 2023..
21/2/202423:05PRNUSREGENXBIO to Host Conference Call on February 27 to Discuss..
17/2/202410:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202403:40PRNUSREGENXBIO Announces Pivotal Trial of RGX-121 for the..
07/2/202423:05PRNUSREGENXBIO Announces Completion of Enrollment in Cohort 2 and..
31/1/202423:05PRNUSREGENXBIO Announces Presentations at the 20th Annual..
19/1/202410:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202408:22EDGAR2Form 144 - Report of proposed sale of securities
17/1/202406:47PRNUSREGENXBIO Announces Positive Interim Data from Phase II..
10/1/202423:05PRNUSREGENXBIO Announces Presentation at the Hawaiian Eye and..
08/1/202423:05PRNUSU.S. District Court Issues Decision on REGENXBIO and..
05/1/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:21EDGAR2Form 144 - Report of proposed sale of securities
22/12/202305:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202308:29EDGAR2Form 144 - Report of proposed sale of securities
29/11/202323:05PRNUSREGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE®..
09/11/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:10EDGAR2Form 8-K - Current report
09/11/202308:05PRNUSREGENXBIO Announces Updated Strategic Plans and Third..
07/11/202323:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
04/11/202309:53PRNUSREGENXBIO Presents Positive One Year Data from Phase II..
01/11/202322:05PRNUSREGENXBIO to Host Conference Call on November 8 to Discuss..
30/10/202322:05PRNUSREGENXBIO Announces Presentations at the American Academy of..
05/10/202322:05PRNUSREGENXBIO to Participate in the Jefferies CNS/Neuro Summit
04/10/202307:05PRNUSREGENXBIO Presents Interim Clinical Data from Phase I/II..
26/9/202321:05PRNUSREGENXBIO Announces Presentations at the 28th Annual..
05/9/202321:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
02/9/202306:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/9/202306:12EDGAR2Form 8-K - Current report
30/8/202321:05PRNUSInitial Clinical Data of First Pediatric CLN2 Patient Dosed..
24/8/202306:05PRNUSREGENXBIO Announces Presentations at the Society for the..

Your Recent History

Delayed Upgrade Clock